Antiphospholipid syndrome and endocrine damage: Why bilateral adrenal thrombosis?

European Journal of Haematology

Volumn 71, Issue 4, 2003, Pages 299-302

  Berneis, Kaspar ^b   Buitrago Téllez, Carlos ^a   Müller, Beat ^a   Keller, Ulrich ^a   Tsakiris, Dimitrios A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

Adrenal failure; Antiphospholipid antibodies; Late endosomes

Indexed keywords

ADRENAL HEMORRHAGE; ADRENAL INSUFFICIENCY; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CASE STUDY; CELL ORGANELLE; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENDOSOME; FEMALE; FUNCTIONAL ANATOMY; HUMAN; INFARCTION; LABORATORY TEST; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN TARGETING; ZONA FASCICULATA;

ADRENAL GLANDS; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ENDOCRINE SYSTEM; ENDOSOMES; EPITOPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; THROMBOSIS; TIME FACTORS;

EID: 0141651533     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00145.x     Document Type: Article

References (19)

1. ARNOUT J, VERMYLEN J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. Thromb Haemost 2003;1:931-942.
2. GREAVES M. Antiphospholipid antibodies and thrombosis. Lancet 1999;354:1031.
3. LEVINE JS, BRANCH DW, RAUCH J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
4. RAND JH, WU. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome. Thromb Haemost 1999;82:649-655.
5. CAREY RM. The changing clinical spectrum of adrenal insufficiency. Ann Intern Med 1997;127:1103-1105.
6. ESPINOSA G, SANTOS E, CERVERA R, PIETTE JC, DE LA RG, GIL V, et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003;82:106-118.
7. VLOT AJ, VAN DER MOLEN AJ, MUIS MJ, FIJNHEER R. Antibodies that stop the adrenals in their tracks. Lancet 2001;358:382.
8. SATTA MA, CORSELLO SM, DELLA CS, ROTA CA, PIROZZI B, COLASANTI S, et al. Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) 2000;52:123-126.
9. TAKEBAYASHI K, ASO Y, TAYAMA K, TAKEMURA Y, INUKAI T. Primary antiphospholipid syndrome associated with acute adrenal failure. Am J Med Sci 2003;325:41-44.
10. LOCKHART ME, SMITH JK, KENNEY PJ. Imaging of adrenal masses. Eur J Radiol 2002;41:95-112.
11. KOBAYASHI T, BEUCHAT MH, LINDSAY M, FRIAS S, PALMITER RD, SAKURABA H, et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1999;1:113-118.
12. GALVE-DE ROCHEMONTEIX B, KOBAYASHI T, ROSNOBLET C, LINDSAY M, PARTON RG, REBER G et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:563-574.
13. DUNOYER-GEINDRE S, KRUITHOF EK, GALVE-DE ROCHEMONTEIX B, ROSNOBLET C, GRUENBERG J, REBER G, et al. Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells. Thromb Haemost 2001;85:903-907.
14. SORICE M, FERRO D, MISASI R, PITTONI V, LONGO A, CIRCELLA A, et al. Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost 2002;87:735-741.
15. PIERANGELI SS, COLDEN-STANFIELD M, LIU X, BARKER JH, ANDERSON GL, HARRIS EN. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999;20:1997-2002.
16. KAPLANSKI G, CACOUB P, FARNARIER C, MARIN V, GREGOIRE R, GATEL A, et al. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum 2000;43:55-64.
17. HANLY JG, SMITH SA. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol 2000;120:537-543.
18. NAKAMURA N, BAN T, YAMAJI K, YONEDA Y, WADA Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest 1998;101:1951-1959.
19. KAWAMINAMI M, KAWAMOTO T, TANABE T, YAMAGUCHI K, MUTOH K, KURUSU S, et al. Immunocytochemical localization of annexin 5, a calcium-dependent phospholipid-binding protein, in rat endocrine organs. Cell Tissue Res 1998;292:85-89.